XML 189 R42.htm IDEA: XBRL DOCUMENT v3.25.1

Equity (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2025

Dec. 31, 2024

Equity (Tables) [Line Items]

Schedule of Common Stock Issuable Upon Exercise of Warrants Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of options outstanding at December 31, 2024:

Options Outstanding																Options Exercisable
Range of Exercise Price				Number Outstanding at December 31, 2024				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at December 31, 2024				Weighted Average Exercise Price
$	2.93 - 31.20				20,198				3.54			$	14.76				14,591			$	16.38
	48.75 - 123.00				20,517				2.04				78.91				20,517				78.91
	154.50 - 289.50				11,764				3.44				218.21				11,764				218.21
$	2.93 - 289.50				52,479				2.93			$	85.45				46,872			$	94.41

Schedule of Stock Option Activity

Stock option activity for the three months ended March 31, 2025 was as follows:

		Number of Options				Weighted Average Exercise Price
Outstanding at January 1, 2025			52,479			$	85.45
Granted			2,665				3.26
Expired / cancelled			(3,719	)			(132.47	)
Outstanding at March 31, 2025			51,425			$	77.79
Options exercisable at March 31, 2025			47,493			$	83.97
Options expected to vest			3,932			$	3.13

Stock warrant activity for the three months ended March 31, 2025 was as follows:

		Number of Warrants				Weighted Average Exercise Price
Outstanding at January 1, 2025			182,996			$	21.37
Exercised			(11,833	)			(58.63	)
Outstanding at March 31, 2025			171,163			$	18.79
Warrants exercisable at March 31, 2025			91,163			$	28.70
Warrants expected to vest			80,000			$	7.50

Stock option activity for the years ended December 31, 2024 and 2023 was as follows:

		Number of Options				Weighted Average Exercise Price
Outstanding at January 1, 2023			53,357			$	195.45
Granted			12,452				35.25
Expired			(8,929	)			(267.90	)
Outstanding at December 31, 2023			56,880				149.03
Granted			10,265				4.13
Expired			(14,666	)			(275.14	)
Outstanding at December 31, 2024			52,479			$	85.45
Options exercisable at December 31, 2024			46,872			$	94.41
Options expected to vest			5,607			$	10.56

Stock warrant activity for the years ended December 31, 2024 and 2023 was as follows:

		Number of Warrants				Weighted Average Exercise Price
Outstanding at January 1, 2023			8,264			$	187.50
Issued			34,771				48.90
Outstanding at December 31, 2023			43,035				75.53
Issued			169,527				10.28
Cancelled (*)			(23,288	)			(32.85	)
Exercised			(6,278	)			(50.77	)
Outstanding at December 31, 2024			182,996			$	21.37
Warrants exercisable at December 31, 2024			102,996			$	32.13
Warrants expected to vest			80,000			$	7.50

Schedule of Nonvested Stock Options Granted

A summary of the status of the Company’s nonvested stock options granted as of March 31, 2025 and changes during the three months ended March 31, 2025 is presented below:

		Number of Options				Weighted Average Exercise Price
Nonvested at January 1, 2025			5,943			$	11.54
Granted			2,665				3.26
Cancelled			(1,853	)			(27.40	)
Vested			(2,823	)			(5.03	)
Nonvested at March 31, 2025			3,932			$	3.13

A summary of the status of the Company’s nonvested stock warrants issued as of March 31, 2025 and changes during the three months ended March 31, 2025 is presented below:

		Number of Warrants				Weighted Average Exercise Price
Nonvested at January 1, 2025			80,000			$	7.50
Vested			-				-
Nonvested at March 31, 2025			80,000			$	7.50

A summary of the status of the Company’s nonvested stock options granted as of December 31, 2024 and changes during the years ended December 31, 2024 and 2023 is presented below:

		Number of Options				Weighted Average Exercise Price
Nonvested at January 1, 2023			1,334			$	64.35
Granted			12,452				35.25
Vested			(8,475	)			(47.14	)
Nonvested at December 31, 2023			5,311				23.55
Granted			10,265				4.13
Vested			(9,969	)			(10.90	)
Nonvested at December 31, 2024			5,607			$	10.56

A summary of the status of the Company’s nonvested stock warrants issued as of December 31, 2024 and changes during the years ended December 31, 2024 and 2023 was presented below:

		Number of Warrants				Weighted Average Exercise Price
Nonvested at January 1, 2023			-			$	-
Issued			34,771				48.90
Vested			(19,560	)			55.95
Nonvested at December 31, 2023			15,211				39.90
Issued			169,527				10.28
Cancelled			(23,288	)			(32.85	)
Vested			(81,450	)			(12.10	)
Nonvested at December 31, 2024			80,000			$	7.50

Schedule of Common Stock Issuable Upon Exercise of Options Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at December 31, 2024:

Warrants Outstanding																Warrants Exercisable
Range of Exercise Price					Number Outstanding at December 31, 2024				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at December 31 , 2024				Weighted Average Exercise Price
$	7.50 - 37.50				165,510				4.40			$	10.50				85,510			$	13.31
	67.50				9,222				3.40				67.50				9,222				67.50
	187.50				8,264				2.30				187.50				8,264				187.50
$	7.50 - 187.50				182,996				4.25			$	21.37				102,996			$	32.13

* Second Warrant, which was issued on May 23, 2023, July 6, 2023, October 9, 2023, and March 7, 2024, was cancelled in June 2024. Second Warrant, which was issued on June 5, 2024, is still outstanding as of December 31, 2024.

Options [Member]

Equity (Tables) [Line Items]

Schedule of Common Stock Issuable Upon Exercise of Options Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of options outstanding at March 31, 2025:

Options Outstanding																Options Exercisable
Range of Exercise Price				Number Outstanding at March 31, 2025				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at March 31, 2025				Weighted Average Exercise Price
$	2.93 - 31.20			21,010				3.48			$	12.19				17,078			$	14.28
48.75 - 123.00				20,517				1.79				78.91				20,517				78.91
154.50 - 264.00				9,898				3.82				214.71				9,898				214.71
$	2.93 - 264.00			51,425				2.87			$	77.79				47,493			$	83.97

Warrants Outstanding [Member]

Equity (Tables) [Line Items]

Schedule of Common Stock Issuable Upon Exercise of Options Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at March 31, 2025:

	Warrants Outstanding														Warrants Exercisable
Range of Exercise Price			Number Outstanding at March 31, 2025				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at March 31, 2025				Weighted Average Exercise Price
$	7.50 - 37.50			162,010				4.17			$	9.92				82,010			$	12.27
	67.50			889				3.18				67.50				889				67.50
	187.50			8,264				2.06				187.50				8,264				187.50
$	7.50 - 187.50			171,163				4.06			$	18.79				91,163			$	28.70

X

- References

No definition available.

+ Details

Name:	avco_EquityTablesLineItems
Namespace Prefix:	avco_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_AwardTypeAxis=avco_OptionsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=avco_WarrantsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: